MX9306032A - Adenosinas 2-sustituidas con afinidad por el receptor a-2. - Google Patents
Adenosinas 2-sustituidas con afinidad por el receptor a-2.Info
- Publication number
- MX9306032A MX9306032A MX9306032A MX9306032A MX9306032A MX 9306032 A MX9306032 A MX 9306032A MX 9306032 A MX9306032 A MX 9306032A MX 9306032 A MX9306032 A MX 9306032A MX 9306032 A MX9306032 A MX 9306032A
- Authority
- MX
- Mexico
- Prior art keywords
- adenosine
- activity
- physiological effects
- adenosins
- affinity
- Prior art date
Links
- 102000009346 Adenosine receptors Human genes 0.000 abstract 3
- 108050000203 Adenosine receptors Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 230000001766 physiological effect Effects 0.000 abstract 2
- 150000003838 adenosines Chemical class 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000003379 purinergic P1 receptor agonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Se describen análogos de la adenosina que actúan selectivamente en los receptores de adenosina y los cuales actúan en general como agonistas de la adenosina. De los estudios in vitro se sabe que los efectos fisiológicos específicos, pueden distinguirse como un resultado de esta selectividad, y que la actividad del receptor adenosina in vitro se correlaciona con la actividad del receptor adenosina in vivo. Las preparaciones farmacéuticas de los compuestos objetivo, pueden prepararse con base a la actividad de enlace selectivo de los compuestos descritos en la presente, las cuales aumentarán ciertos efectos fisiológicos mientras que reducen al mínimo otros, tales como disminución de la presión sanguínea sin disminuir la frecuencia cardiaca.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95418092A | 1992-09-30 | 1992-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9306032A true MX9306032A (es) | 1994-03-31 |
Family
ID=25495051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9306032A MX9306032A (es) | 1992-09-30 | 1993-09-29 | Adenosinas 2-sustituidas con afinidad por el receptor a-2. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0662975B1 (es) |
| JP (1) | JPH08502069A (es) |
| KR (1) | KR100316354B1 (es) |
| AT (1) | ATE150761T1 (es) |
| AU (1) | AU672226B2 (es) |
| CA (1) | CA2145682C (es) |
| DE (1) | DE69309293T2 (es) |
| DK (1) | DK0662975T3 (es) |
| ES (1) | ES2102679T3 (es) |
| FI (1) | FI109129B (es) |
| GR (1) | GR3023761T3 (es) |
| HU (1) | HU220760B1 (es) |
| IL (2) | IL107101A0 (es) |
| MX (1) | MX9306032A (es) |
| NO (1) | NO303875B1 (es) |
| NZ (1) | NZ256195A (es) |
| TW (1) | TW302367B (es) |
| WO (1) | WO1994007905A1 (es) |
| ZA (1) | ZA937108B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6921753B2 (en) | 2000-06-27 | 2005-07-26 | Pfizer Inc | Purine derivatives |
| GB0015727D0 (en) * | 2000-06-27 | 2000-08-16 | Pfizer Ltd | Purine derivatives |
| GB0022695D0 (en) | 2000-09-15 | 2000-11-01 | Pfizer Ltd | Purine Derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034381A (en) * | 1988-01-07 | 1991-07-23 | Ciba-Geigy Corporation | 2-(substituted amino) adenosines as antihypertensives |
-
1992
- 1992-09-24 IL IL107101A patent/IL107101A0/xx unknown
-
1993
- 1993-09-02 AT AT93921304T patent/ATE150761T1/de not_active IP Right Cessation
- 1993-09-02 ES ES93921304T patent/ES2102679T3/es not_active Expired - Lifetime
- 1993-09-02 JP JP6509058A patent/JPH08502069A/ja active Pending
- 1993-09-02 HU HU9500918A patent/HU220760B1/hu not_active IP Right Cessation
- 1993-09-02 AU AU48446/93A patent/AU672226B2/en not_active Ceased
- 1993-09-02 CA CA002145682A patent/CA2145682C/en not_active Expired - Fee Related
- 1993-09-02 EP EP93921304A patent/EP0662975B1/en not_active Expired - Lifetime
- 1993-09-02 WO PCT/US1993/008269 patent/WO1994007905A1/en not_active Ceased
- 1993-09-02 NZ NZ256195A patent/NZ256195A/en unknown
- 1993-09-02 DE DE69309293T patent/DE69309293T2/de not_active Expired - Fee Related
- 1993-09-02 KR KR1019950701220A patent/KR100316354B1/ko not_active Expired - Fee Related
- 1993-09-02 DK DK93921304.7T patent/DK0662975T3/da active
- 1993-09-24 ZA ZA937108A patent/ZA937108B/xx unknown
- 1993-09-24 IL IL10710193A patent/IL107101A/xx not_active IP Right Cessation
- 1993-09-25 TW TW082107911A patent/TW302367B/zh active
- 1993-09-29 MX MX9306032A patent/MX9306032A/es not_active IP Right Cessation
-
1995
- 1995-03-29 NO NO951213A patent/NO303875B1/no unknown
- 1995-03-29 FI FI951500A patent/FI109129B/fi active
-
1997
- 1997-06-11 GR GR970401405T patent/GR3023761T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ256195A (en) | 1996-05-28 |
| HU9500918D0 (en) | 1995-05-29 |
| FI109129B (fi) | 2002-05-31 |
| IL107101A0 (en) | 1993-12-28 |
| HUT72611A (en) | 1996-05-28 |
| NO303875B1 (no) | 1998-09-14 |
| KR100316354B1 (ko) | 2002-09-26 |
| IL107101A (en) | 2000-07-16 |
| NO951213D0 (no) | 1995-03-29 |
| NO951213L (no) | 1995-03-29 |
| DE69309293D1 (de) | 1997-04-30 |
| TW302367B (es) | 1997-04-11 |
| GR3023761T3 (en) | 1997-09-30 |
| CA2145682A1 (en) | 1994-04-14 |
| JPH08502069A (ja) | 1996-03-05 |
| AU672226B2 (en) | 1996-09-26 |
| FI951500L (fi) | 1995-03-29 |
| EP0662975A1 (en) | 1995-07-19 |
| CA2145682C (en) | 1998-11-10 |
| HU220760B1 (hu) | 2002-05-28 |
| ES2102679T3 (es) | 1997-08-01 |
| DE69309293T2 (de) | 1997-07-10 |
| FI951500A0 (fi) | 1995-03-29 |
| WO1994007905A1 (en) | 1994-04-14 |
| ZA937108B (en) | 1994-05-17 |
| DK0662975T3 (es) | 1997-04-28 |
| AU4844693A (en) | 1994-04-26 |
| ATE150761T1 (de) | 1997-04-15 |
| KR950703572A (ko) | 1995-09-20 |
| EP0662975B1 (en) | 1997-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2086313T3 (es) | Nuevos derivados de xantina con efecto antagonista de adenosina. | |
| ES2173873T3 (es) | Utilizacion de anticuerpos anti-vegf para el tratammiento del cancer. | |
| RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
| GT199900070A (es) | Derivados de isotiazol, utiles como agentes anticancerosos. | |
| ES2196063T3 (es) | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| NZ221611A (en) | Imidazolylguanidine derivatives and pharmaceutical compositions | |
| MX9306032A (es) | Adenosinas 2-sustituidas con afinidad por el receptor a-2. | |
| ES2054724T3 (es) | Receptor del pequeño grupo de receptores de rinovirus. | |
| AR031641A1 (es) | Combinacion inmunoterapeutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina | |
| ATE59781T1 (de) | Potenzierung von prazosin. | |
| ES8403896A1 (es) | Un procedimiento para la preparacion del isomero levogiro de la 10-(c1-aza 3-biciclo (2,2,2) octil) metil) 10h-fonotiazina. | |
| MX9403382A (es) | Xantinas sustituidas en la posicion 8 como agentes receptores selectivosde adenosina. | |
| AR013308A1 (es) | Metodos para seleccionar compuestos utiles en la regulacion del peso corporal | |
| ES2093612T3 (es) | Neoglucoproteinas, su preparacion y empleo. | |
| DK197586D0 (da) | Fremgangsmaade til fremstilling af 17alfa-ethynyl-17beta-hydroxy-18-methyl-4,15-oestradien-3-on og udgangsforbindelser til denne fremgangsmaade | |
| CA2013381A1 (en) | Selective adenosine receptor compounds | |
| DE3883044D1 (de) | Wirkstoff zur tumorbekaempfung. | |
| IT7829209A0 (it) | Prodotto di condensazione ottenuto da fenotiazina e da p-nitrosofenolo, procedimento per la preparazione del prodotto di condensazione, procedimento per lapreparazione di coloranti allo zolfo con impiego del prodotto di condensazione e i coloranti allo zolfo preparati. | |
| ES2173027R (es) | ||
| ES2163661T3 (es) | Propanolol fluorado y metodos asociados. | |
| IT208524Z2 (it) | Telo attrezzato, atto ad isolare un arto, destinato ad interventi chirurgici, di un paziente, dal tronco del paziente stesso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |